Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention

Carmine Savoia, Lidia Sada, Massimo Volpe

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Hypertension is one of the major risk factors for atrial fibrillation which in turn is the most prevalent concomitant condition in hypertensive patients. While both these pathological conditions are independent risk factors for stroke, the association of hypertension and atrial fibrillation increases the incidence of disabling strokes. Moreover, documented or silent atrial fibrillation doubles the rate of cardiovascular death. Lowering blood pressure is strongly recommended, particularly for primary stroke prevention. However, a relatively small percentage of hypertensive patients still achieve the recommended blood pressure goals. The management of atrial fibrillation with respect to stroke prevention is changing. New oral anticoagulants represent a major advancement in long-term anticoagulation therapy in non valvular atrial fibrillation. They have several benefits over warfarin, including improved adherence to the anticoagulation therapy. This is an important issue since non-adherence to stroke prevention medications is a risk factor for first and recurrent strokes.

Original languageEnglish
JournalCurrent Hypertension Reports
Volume17
Issue number6
DOIs
Publication statusPublished - Jun 1 2015

Fingerprint

Atrial Fibrillation
Stroke
Blood Pressure
Hypertension
Warfarin
Primary Prevention
Anticoagulants
Mortality
Incidence
Therapeutics

Keywords

  • Antihypertensive drugs
  • ARBs
  • Blood pressure control
  • NOACs
  • Oral anticoagulants

ASJC Scopus subject areas

  • Internal Medicine
  • Medicine(all)

Cite this

Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention. / Savoia, Carmine; Sada, Lidia; Volpe, Massimo.

In: Current Hypertension Reports, Vol. 17, No. 6, 01.06.2015.

Research output: Contribution to journalArticle

@article{63ff6d185f1e43879929bb641441faf9,
title = "Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention",
abstract = "Hypertension is one of the major risk factors for atrial fibrillation which in turn is the most prevalent concomitant condition in hypertensive patients. While both these pathological conditions are independent risk factors for stroke, the association of hypertension and atrial fibrillation increases the incidence of disabling strokes. Moreover, documented or silent atrial fibrillation doubles the rate of cardiovascular death. Lowering blood pressure is strongly recommended, particularly for primary stroke prevention. However, a relatively small percentage of hypertensive patients still achieve the recommended blood pressure goals. The management of atrial fibrillation with respect to stroke prevention is changing. New oral anticoagulants represent a major advancement in long-term anticoagulation therapy in non valvular atrial fibrillation. They have several benefits over warfarin, including improved adherence to the anticoagulation therapy. This is an important issue since non-adherence to stroke prevention medications is a risk factor for first and recurrent strokes.",
keywords = "Antihypertensive drugs, ARBs, Blood pressure control, NOACs, Oral anticoagulants",
author = "Carmine Savoia and Lidia Sada and Massimo Volpe",
year = "2015",
month = "6",
day = "1",
doi = "10.1007/s11906-015-0553-1",
language = "English",
volume = "17",
journal = "Current Hypertension Reports",
issn = "1522-6417",
publisher = "Current Medicine Group",
number = "6",

}

TY - JOUR

T1 - Blood Pressure Control versus Atrial Fibrillation Management in Stroke Prevention

AU - Savoia, Carmine

AU - Sada, Lidia

AU - Volpe, Massimo

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Hypertension is one of the major risk factors for atrial fibrillation which in turn is the most prevalent concomitant condition in hypertensive patients. While both these pathological conditions are independent risk factors for stroke, the association of hypertension and atrial fibrillation increases the incidence of disabling strokes. Moreover, documented or silent atrial fibrillation doubles the rate of cardiovascular death. Lowering blood pressure is strongly recommended, particularly for primary stroke prevention. However, a relatively small percentage of hypertensive patients still achieve the recommended blood pressure goals. The management of atrial fibrillation with respect to stroke prevention is changing. New oral anticoagulants represent a major advancement in long-term anticoagulation therapy in non valvular atrial fibrillation. They have several benefits over warfarin, including improved adherence to the anticoagulation therapy. This is an important issue since non-adherence to stroke prevention medications is a risk factor for first and recurrent strokes.

AB - Hypertension is one of the major risk factors for atrial fibrillation which in turn is the most prevalent concomitant condition in hypertensive patients. While both these pathological conditions are independent risk factors for stroke, the association of hypertension and atrial fibrillation increases the incidence of disabling strokes. Moreover, documented or silent atrial fibrillation doubles the rate of cardiovascular death. Lowering blood pressure is strongly recommended, particularly for primary stroke prevention. However, a relatively small percentage of hypertensive patients still achieve the recommended blood pressure goals. The management of atrial fibrillation with respect to stroke prevention is changing. New oral anticoagulants represent a major advancement in long-term anticoagulation therapy in non valvular atrial fibrillation. They have several benefits over warfarin, including improved adherence to the anticoagulation therapy. This is an important issue since non-adherence to stroke prevention medications is a risk factor for first and recurrent strokes.

KW - Antihypertensive drugs

KW - ARBs

KW - Blood pressure control

KW - NOACs

KW - Oral anticoagulants

UR - http://www.scopus.com/inward/record.url?scp=84928622236&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928622236&partnerID=8YFLogxK

U2 - 10.1007/s11906-015-0553-1

DO - 10.1007/s11906-015-0553-1

M3 - Article

C2 - 25893476

AN - SCOPUS:84928622236

VL - 17

JO - Current Hypertension Reports

JF - Current Hypertension Reports

SN - 1522-6417

IS - 6

ER -